Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function
Heterologous prime-boost strategies hold promise for vaccination against tuberculosis. However, the T-cell characteristics required for protection are not known. We proposed that boost vaccines should induce long-lived functional and phenotypic changes to T cells primed by Bacille Calmette Guerin (B...
Main Authors: | Dintwe, One B, Day, Cheryl L, Smit, Erica, Nemes, Elisa, Gray, Clive, Tameris, Michele, McShane, Helen, Mahomed, Hassan, Hanekom, Willem A, Scriba, Thomas J |
---|---|
Format: | Online |
Language: | English |
Published: |
Wiley-VCH Verlag GmbH & Co
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816254/ |
Similar Items
-
The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
by: Tameris, Michele, et al.
Published: (2014) -
Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis
by: Hatherill, Mark, et al.
Published: (2006) -
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
by: McShane, Helen, et al.
Published: (2016) -
The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children
by: Mulenga, Humphrey, et al.
Published: (2015) -
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
by: Tameris, Michele, et al.
Published: (2013)